Your browser doesn't support javascript.
loading
Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4.
Lian, Bo; Wei, Hua; Pan, Ruiyan; Sun, Jingui; Zhang, Bo; Wu, Jingliang; Li, Xiujie; Tian, Guixiang.
Afiliação
  • Lian B; School of Bioscience and Technology, Weifang Medical University, Weifang 261053, People's Republic of China.
  • Wei H; Department of Endocrinology, ShouGuang Peoples' Hospital, Weifang 262700, People's Republic of China.
  • Pan R; School of Pharmacy, Weifang Medical University, Weifang 261053, People's Republic of China.
  • Sun J; Department of Oncology, ShouGuang Peoples' Hospital, Weifang 262700, People's Republic of China.
  • Zhang B; School of Pharmacy, Weifang Medical University, Weifang 261053, People's Republic of China.
  • Wu J; School of Bioscience and Technology, Weifang Medical University, Weifang 261053, People's Republic of China.
  • Li X; School of Bioscience and Technology, Weifang Medical University, Weifang 261053, People's Republic of China.
  • Tian G; School of Bioscience and Technology, Weifang Medical University, Weifang 261053, People's Republic of China.
Int J Nanomedicine ; 16: 457-467, 2021.
Article em En | MEDLINE | ID: mdl-33488080
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estilbenos / Doxorrubicina / Galactose / Lipossomos Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estilbenos / Doxorrubicina / Galactose / Lipossomos Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article